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ABSTRACT 12 
Environmental analytical chemists face the challenge of investigating thousands of potential 13 
organic pollutants that may be present in the aquatic environment. High resolution mass 14 
spectrometry (HRMS) hyphenated to chromatography offers the possibility of detecting a 15 
large number of contaminants without pre-selection of analytes due to its accurate-mass full-16 
spectrum acquisition at good sensitivity. Interestingly, large screening can be made even 17 
without reference standards, as the valuable information provided by HRMS allows the 18 
tentative identification of the compound detected. In this work, hybrid quadrupole time-of-19 
flight (QTOF) MS was combined with both liquid and gas chromatography (using a single 20 
instrument) for screening of around 2,000 compounds in waters. This was feasible thanks to 21 
the use of atmospheric pressure chemical ionization source in GC. The screening was 22 
qualitatively validated for around 300 compounds at three levels (0.02, 0.1, 0.5 µg/L), and 23 
screening detection limits were established. Surface, ground water and effluent wastewater 24 
samples were analyzed, detecting and identifying a notable number of pesticides and 25 
transformation products, pharmaceuticals, personal care products, and illicit drugs, among 26 
others. This is one of the most universal approaches in terms of comprehensive measurement 27 
for broad screening of organic contaminants within a large range of polarity and volatility in 28 
waters. 29 
 30 
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 34 
1. INTRODUCTION 35 
Over the last decades, environmental pollution has become a matter of increasing concern 36 
due to the high number of both regulated and unregulated organic pollutants that can be 37 
present in environmental waters. The majority of these compounds, such as pesticides, 38 
pharmaceuticals, drugs of abuse, surfactants, biocides, personal care products, sweeteners, 39 
etc. are originated by human use. They can enter in the surface water (and even groundwater) 40 
mainly via treated and untreated wastewater [1-2].  Despite the evident advances in analytical 41 
chemistry, the comprehensive determination of organic contaminants in waters is still a 42 
challenge at present. The main difficulty arises from the elevated number of compounds (in 43 
addition to their metabolites and/or transformation products) that may be present in the 44 
samples. This fact, together with the very different physico-chemical properties of analytes, 45 
makes the application of a single analytical methodology, appropriate for all potential 46 
contaminants, unfeasible. 47 
Most analytical methods developed until now have used chromatographic techniques coupled 48 
to mass spectrometry (MS) analyzers, as single quadrupole or ion trap, and in the last decade, 49 
triple quadrupole. In these target methods, the list of analytes rarely exceeds 200-300 50 
compounds, and relevant contaminants other than the target analytes that might be present in 51 
the samples are commonly ignored. Therefore, there is a need for the development of wide-52 
scope “universal” screening methods able to detect and identify a long list of contaminants, 53 
offering in this way more realistic and complete information on undesirable compounds 54 
present in environmental samples. 55 
Full spectrum acquisition techniques such as high resolution mass spectrometry (HRMS) 56 
offer the possibility for screening a huge number of contaminants in post-targeted approaches 57 
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(i.e. the selection of compounds to be searched is made once mass data have been acquired) 58 
without the need of pre-selecting the analytes for method development. Besides, the 59 
subsequent searching of any other compound at any time, in a retrospective analysis, is also 60 
feasible without the need of new sample injections. An additional value of HRMS is that it 61 
provides accurate-mass full-spectra data with reasonable sensitivity [3]. Interestingly, search 62 
and detection of contaminants can be made even without reference standards, as the valuable 63 
information provided by HRMS commonly allows reliable tentative identifications [4]. 64 
Time of flight (TOF) and Orbitrap analyzers have been frequently used in LC-HRMS based 65 
methods for screening of many different families of contaminants in the aquatic environment. 66 
Target analytes include compounds of medium/high polarity compatible with LC analysis 67 
(e.g. many pesticides, pharmaceuticals -antibiotics included-, illicit drugs, veterinary drugs, 68 
etc.) [5-12].  69 
As a complement to LC-MS methods, GC-MS allows to investigate GC-amenable 70 
contaminants, such as polychlorinated biphenyls (PCBs), polycyclic aromatic hydrocarbons 71 
(PAHs), polybrominated diphenyl ethers (PBDEs), and certain pesticides, among others. 72 
Although single nominal analyzers like single quadrupole, ion trap or triple quadrupole can 73 
be used to this aim, HRMS is a superior technique for screening purposes, for the same 74 
reasons indicated above. With the exception of analysis of dioxins and related compounds 75 
using magnetic sectors [5], GC-HRMS has seldom been explored in environmental pollution 76 
monitoring until recently. The first applications of GC-HR TOF MS were reported in 77 
2004[13-15]. Almost all applications have dealt with the determination of persistent and other 78 
priority pollutants in environmental [3,16] and biological fields [17-18]. Electron ionization 79 
(EI) source is the preferred ionization technique and the most widely applied due to its 80 
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robustness, reproducibility and the existence of standardized commercial spectra libraries, 81 
which facilitates the identification of compounds. There is a number of databases available 82 
(for example, NIST) that have already designed non-target tools (such as AMDIS) that 83 
identify fragments and match them against a database of over 200,000 individual compounds 84 
obtaining satisfactory results and making this approach a reference in the field [19-20].  85 
However, EI commonly leads to extensive fragmentation. EI mass spectra are characterized 86 
by an abundance of fragment ions and in many cases the molecular ion is absent or has low 87 
abundance. In the last few years, the atmospheric pressure chemical ionization (APCI) source 88 
has been implemented in GC-MS instruments offering attractive features for screening. The 89 
soft and universal ionization in this source leads to the presence of abundant molecular ion 90 
and/or protonated molecule in the mass spectra, facilitating the sensitive and selective 91 
detection of analytes in the samples [21-22]. The availability of this source has allowed the 92 
combined use of GC and LC coupled to TOF MS, a combination that appears nowadays as 93 
one of the most potent approaches for large screening. The use of a single TOF platform 94 
coupled to both GC and LC opens fascinating perspectives in the environmental field. A huge 95 
number of compounds, from low polarity and/or high volatility (GC-amenable compounds) 96 
to high polarity and/or low volatility (LC-compounds), can be investigated with satisfactory 97 
sensitivity and excellent performance in terms of detection and identification/elucidation 98 
purposes. Even more useful is hybrid quadrupole time-of-flight (QTOF MS), which offers 99 
additional possibilities for identification, such as the acquisition of low (LE) and high 100 
collision energy (HE) spectra in one run, or performing additional MS/MS experiments. 101 
The aim of this work is to evaluate the potential of QTOF MS coupled to both LC and GC 102 
(using a single instrument) for screening of more than 2,000 compounds in water samples of 103 
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different origin and matrix compositions. This strategy has not been explored in the 104 
environmental field until now. The method has been qualitatively validated in different water 105 
samples (surface water, groundwater and wastewater) for hundreds of selected compounds 106 
(141 for LC and 166 for GC, with some compounds having been evaluated by both 107 
techniques) at three concentrations (0.02, 0.1 and 0.5 µg/L). The screening procedure has 108 
subsequently been applied to water samples, allowing the detection and identification of a 109 
high number of organic contaminants. Tentative identifications of compounds detected have 110 
been made when the reference standards were unavailable, on the basis of 1) accurate mass 111 
(mass errors) of the molecular ion, commonly in the LE spectrum; 2) main fragments 112 
observed, typically in the HE spectrum; and 3) isotopic distribution.  113 
 114 
 115 
2. EXPERIMENTAL 116 
2.1. Reagents and chemicals 117 
Information on reagents and chemicals used in this work is shown in Supplementary 118 
Information.  119 
 120 
2.2. Instrumentation  121 
A hybrid quadrupole-orthogonal acceleration-TOF mass spectrometer (Xevo G2 QTOF, 122 
Waters Micromass, Manchester, UK) was interfaced to a Waters Acquity UPLC system 123 
(Waters, Milford, MA, USA) or to an Agilent 7890A GC system (Palo Alto, CA, USA), 124 
using a single instrument. For details, see Supplementary Information. 125 
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For MSE experiments, two acquisition functions with different collision energies were 126 
created: the low energy (LE) function, selecting as collision energy 4eV, and the high energy 127 
(HE) function, with a collision energy ramp from 10 to 40 eV.  128 
Data were automatically processed by ChromaLynx XS (target mode) software (MassLynx 129 
v 4.1, Waters).  130 
 131 
2.3. Water samples 132 
Several groundwater (GW) (12 samples), surface water (SW) (12 samples) and effluent 133 
wastewater (EWW) (9 samples) were collected from the Spanish Mediterranean area of 134 
Valencia during July 2012and analyzed to investigate the presence of organic contaminants. 135 
This is an important agricultural area, with predominance of citrus crops; therefore, the 136 
presence of pesticides is expected in environmental samples. SW were collected from rivers 137 
(2), reservoirs (2) and lakes (8), whereas GW samples were collected from 12 different wells 138 
located in the Castellon area. EWW were collected from different WWTPs of the same area. 139 
Concretely, they were sampled from Nules, Vall d’Uixó, Castelló de la Plana and 140 
Benicàssim. All samples were stored in darkness at <−18 ◦C in polyethylene high-density 141 
bottles until analysis. Immediately before analysis, samples were thawed at room 142 
temperature. 143 
 144 
2.4 Sample treatment 145 
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Figure 1 illustrates the screening methodology applied. Samples were analysed by UHPLC-146 
ESI-(Q)TOF MS and GC-APCI-(Q)TOF MS, after a generic solid-phase extraction (SPE) 147 
(see Figure 1a). Briefly, 250 mL of centrifuged water samples were passed by gravity 148 
through Oasis HLB (200 mg, Waters) cartridges, previously conditioned with 5 mL methanol 149 
and 5 mL HPLC-grade water. After drying under vacuum, analytes were eluted with 10 mL 150 
methanol. The extract was divided into 2 aliquots. The 5 mL-GC aliquot was evaporated 151 
under a gentle nitrogen stream at 35ºC down to a volume of 1 mL. Then 1 mL of ethyl acetate 152 
was added and evaporated again to 250 µL (final pre-concentration factor x500). The 5 mL-153 
LC aliquot was evaporated to dryness under a gentle nitrogen stream at 35°C and 154 
reconstituted with 0.5 mL methanol–water (10:90, v/v) (final pre-concentration factor x250). 155 
Finally, 1 and 50 µL of the extracts were injected into the GC-(Q)TOF MS and UHPLC-156 
(Q)TOF MS systems, respectively. 157 
 158 
2.5 Data processing 159 
After injection of the sample extracts, full-spectrum acquisition data generated at low and 160 
high collision energy (MSE) were processed, using the specialized application manager 161 
ChromaLynx XS (within MassLynx) in combination with a home-made database (see Figure 162 
1b). It offers the possibility of applying a “post-target” processing method based on 163 
monitoring theoretical exact masses of selected analytes, obtaining the narrow-window 164 
eXtracted Ion Chromatograms (nw-XICs), commonly at 10-20 mDa. This permits a rapid 165 
and simple reviewing by classifying candidates as a function of the mass error. In addition, 166 
this software allows the simultaneous visualization of the complete mass spectra of positive 167 
findings at LE and HE. This methodology, commonly applied in LC-MS screening, has 168 
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recently become feasible in GC-MS thanks to the availability of the APCI source for GC that 169 
allows the soft ionization leading to the formation of the molecular ion and/or the protonated 170 
molecule as base peak of the spectrum [23]. 171 
In this work, the LC homemade database contained around 1,600 organic contaminants, 172 
including pesticides, pharmaceuticals of human consumption, veterinary drugs, drugs of 173 
abuse, UV-filter agents, X-ray contrast media, colorants, preservatives, and a notable number 174 
of degradation products.  175 
Regarding GC, the database contained 280 compounds, including pesticides, PAHs, PCBs, 176 
PBDEs, fragrances, musks, antimicrobials, insect repellents, UV filters and 177 
polychloronaphthalenes (PCNs).  178 
When reference standards were available at our laboratory, they were injected onto the LC 179 
or GC system, using the same instrumental conditions described in section 2.1 in S.I. 180 
Information about retention time (Rt), the main fragment ions observed, and adduct 181 
formation was then included in the target list (a txt file) in order to facilitate and enhance the 182 
reliability in the identification/elucidation process. When standards were unavailable, the 183 
only information available was the exact mass of the (de)protonated molecule. In the case of 184 
GC-(APCI)QTOF MS analysis, both molecular ion and the protonated molecule were 185 
included in the processing screening method for those compounds whose behavior in the 186 
APCI source had not been previously evaluated. 187 
The strategy applied consisted on evaluating the presence of the (de)protonated 188 
molecule/molecular ion (occasionally adducts), measured at its accurate mass, in the LE 189 
function of both GC and LC QTOF mass data. For this purpose, nw-XICs at the m/z of all 190 
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compounds included in the database were automatically performed in the LE function. Due 191 
to the narrow mass window employed, usually only one single chromatographic peak was 192 
observed at the expected retention time (Rt). Thus, when reference standards were available, 193 
the presence of a chromatographic peak at the expected Rt, together with the evaluation of 194 
the fragment ions, all measured at accurate mass (mass accuracy accepted was ± 2 mDa), and 195 
characteristic isotopic ions, allowed the unequivocal confirmation of the identity of the 196 
compound detected. 197 
When one or more peaks were observed at a given exact mass but the reference standard was 198 
not available at our lab (i.e. information on Rt was unavailable), it was necessary to evaluate 199 
which peak (if any) corresponded to the candidate. Collision induced dissociation (CID) 200 
fragments (in any of the two functions acquired), or characteristic isotopic ions of the same 201 
chromatographic peak, were evaluated. UHPLC and GC were valuable tools for choosing 202 
perfectly co-eluting fragment ions that in principle correspond to the same “precursor”, while 203 
at the same time avoiding spectrum interferences that would complicate the identification 204 
process. MassFragment software (Waters) was used to propose compatible structures from 205 
accurate mass measurements of the observed fragment ions. When available, the tentative 206 
identification was supported by MS/MS product ions reported in the literature for the suspect 207 
compound (either in exact or nominal mass). After a careful evaluation process, the reference 208 
standards (when commercially available) were finally acquired and injected to unequivocally 209 
confirm the identity of the compound.  210 
2.6. Qualitative validation  211 
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In order to evaluate the applicability of the method, a qualitative validation was performed. 212 
For this purpose, a total of nine water samples (3 surface waters, 3 ground waters and 3 213 
effluent wastewaters) were spiked (after centrifugation of the samples) with a standard 214 
mixture of around 250 organic contaminants from different chemical families at three 215 
concentration levels (0.02, 0.1 and 0.5 µg/L). After solid-phase extraction with Oasis HLB, 216 
sample extracts were analyzed by UHPLC-(ESI)QTOF MS and GC-(APCI)QTOF MS and 217 
accurate-mass full-spectrum acquisition data processed. The screening detection limit (SDL) 218 
was established as the lowest concentration tested for which a compound was detected in all 219 
the samples, using the most abundant ion (normally, the (de)protonated molecule or the 220 
molecular ion) at the expected retention time (2.5% deviation tolerance in LC and 0.5% in 221 
GC) measured at its exact mass with a maximum mass error of 2 mDa. 222 
Selectivity, considered as the ability of the method to discriminate between the analyte and 223 
other compounds that might be present in the sample, was tested for every analyte in the 224 
presence of the rest of compounds included in the screening. It was based on the presence of 225 
characteristic m/z ions, measured at accurate mass, for each compound in the LE and HE 226 
spectra.  227 
Specificity, considered as the ability of the detector (supported by the selectivity of the 228 
extraction, clean-up, derivatization or separation, if applicable) to provide signals that 229 
effectively identify the analyte, was checked by analyzing nine “blank” water samples (3 230 
SW, 3 GW and 3 EWW) and also a deionized water sample (blank of procedure). Some of 231 
these non-spiked samples contained several of the organic pollutants under study; therefore, 232 
it was unfeasible to evaluate specificity in these particular cases.  233 
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 234 
3. RESULTS AND DISCUSSION 235 
In this paper, a simple and quite generic approach, based on solid phase extraction (SPE) 236 
using Oasis HLB polymeric cartridges was selected. This sorbent has been frequently used 237 
in multi-residue methods and is able to retain a great variety of contaminants, from non-polar 238 
to rather polar ones. Obviously, in a “universal” method an extensive sample treatment able 239 
to extract all potential contaminants present in the sample would be required; this is, from 240 
ionic to nonpolar analytes, also avoiding potential losses of volatile compounds that might 241 
occur in evaporation steps. However, the approach selected in this work was directed towards 242 
a “universal” sample analysis, trying to detect and identify all compounds that passed the 243 
sample treatment, more than towards a tedious and long sample manipulation. Therefore, a 244 
rather “universal” although simple sample treatment was selected, such as SPE with Oasis 245 
HLB, and the analytical effort was focused on the measurement of the organic pollutants in 246 
the sample.  247 
With the objective of having available analytical methodology for screening of water 248 
samples, able to detect as many contaminants as possible independently on their polarity and 249 
volatility, the approach selected in this work was tested for different water types and 250 
qualitatively validated for a notable number of model compounds in both LC-QTOF MS and 251 
GC-QTOF MS modes. The availability of the APCI source in GC-QTOF MS was relevant 252 
for this purpose, as it allowed to use a common strategy based on searching for the molecular 253 
ion/(de)protonated molecule. The use of this ion, highly abundant in APCI and ESI spectra, 254 
gives more sensitivity and specificity to the screening methodology. 255 
 256 
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3.1. Validation results 257 
Several aqueous matrices were tested in method validation: surface water, groundwater and 258 
effluent wastewater. Three samples of each water type were spiked at 0.02, 0.1 and 0.5 µg/L 259 
for a notable number of selected compounds, and analyzed together with the non-spiked 260 
blank samples. The difficulties encountered when trying to find realistic samples free of all 261 
target analytes must be highlighted. Under these circumstances, those waters previously 262 
analyzed and proven to have less positive findings were selected as “sample blanks” to 263 
facilitate the validation process. Tables S1-S2 of Supplementary Information show the 264 
results obtained by UHPLC-QTOF MS and GC-QTOF MS, respectively. 265 
Figure 2 summarizes the SDL (the lowest SDL obtained either by UHPLC-QTOF MS or by 266 
GC-QTOF MS is shown) for each analyte. As it can be seen, the vast majority of compounds 267 
(around 80%) could be detected at the 0.1 μg/L level, while the percentage of detection 268 
decreased down to 60% at 0.02 μg/L. At the highest level tested, i.e. 0.5 µg/L, more than 269 
90% of the contaminants could be satisfactorily detected in all matrices tested. 270 
Surely, SDLs for several of the more hydrophobic compounds, such as high molecular weight 271 
PCBs, PAHs and pyrethroid pesticides, could be improved if a specific method was applied 272 
for them, e.g. avoiding the use of methanol as SPE eluent (some of these compounds might 273 
not completely elute with this solvent), or using another SPE sorbent as C18. Additionally, 274 
the evaporation step and the subsequent change of the solvent from methanol to ethyl acetate 275 
might lead to losses for volatile compounds. Thus, the sample treatment was selected as a 276 
compromise between efficiency and simplicity trying to avoid an extensive sample handling, 277 
and taking into account that less favorable recoveries might be compensated by a selective 278 
and sensitive measurements of the sample extracts by QTOF MS.  279 
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The consequence of using real-world samples for validation was that several of the “blank” 280 
samples contained some of the contaminants under study. In these particular cases, the SDL 281 
was only established when a minimum of 5 samples were available as a true blank. Thus, 282 
the SDL could not be established when the compound was present in more than 50% of the 283 
samples (see Table 1 and Tables S.1, S.2). 284 
 285 
3.2. Application to routine samples 286 
A total of 33 water samples (12 GW, 12 SW, 9 EWW) collected in different sites of the 287 
Mediterranean Spanish region were analysed following the developed procedure. The 288 
applied screening allowed the detection and identification of a notable number of compounds 289 
in a highly reliable way. In total, 78 pesticides and metabolites/transformation products, 24 290 
pharmaceuticals and metabolites, 4 drugs of abuse and metabolites, 4 preservatives, 2 291 
sweeteners, 2 X-ray agents, 3 PAHs, 2 musks, 5 UV-filters, 1 antimicrobial and 2 insect 292 
repellents were found (see Table S3 in S.I.). The presence of at least two accurate-mass 293 
measured ions (typically the (de)protonated molecule and one fragment ion) was used for 294 
reliable identification. 295 
Triazine herbicides (particularly, terbuthylazine and terbutryn), the insecticides diazinon and 296 
chlorpyrifos-ethyl, and the fungicides thiabendazol, carbendazim and propiconazole, were 297 
the most frequently identified pesticides. Among pharmaceuticals, the antibiotic ofloxacin, 298 
the anti-inflammatory/analgesic drug diclofenac, the angiotensin II receptor antagonists 299 
valsartan and irbesartan, the antidepressant venlafaxine and the anti-epileptic carbamazepine 300 
were the most frequently found. Regarding drugs of abuse, benzoylecgonine (the main 301 
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metabolite of cocaine) was the most detected. Tonalide and octocrylene were the musk and 302 
the UV filter most frequently found in the water samples, respectively. 303 
For most of the compounds detected, reference standards were available and therefore the 304 
identification was straightforward. As an example, Figure S.1 in Supplementary 305 
Information illustrates the detection and identification of the organophosphate insecticide 306 
chlorpyrifos in effluent wastewater by GC-QTOF MS. The protonated molecule was detected 307 
in the LE function, with a mass error of 1.4 mDa, at the expected retention time (21.24 min). 308 
Moreover, the combined spectrum of this chromatographic peak showed a typical three-309 
chlorine atoms isotopic pattern, being therefore in accordance with the chemical structure of 310 
chlorpyrifos (C9H11Cl3NO3PS). Its identity was unequivocally confirmed by the presence of 311 
four m/z ions at the expected retention time in the HE function, with negligible mass errors. 312 
In a few positive samples, the reference standards were not available in our laboratory. 313 
Despite this fact, a tentative identification was possible based on the ions observed 314 
((de)protonated molecule/molecular ion and fragment ions), their compatibility with the 315 
chemical structure of the candidate, and by comparison with the ions reported in the 316 
literature. This was the case of the pesticides tebuconazole, penconazole and myclobutanil, 317 
the veterinary pharmaceutical levamisole (also used as adulterant in cocaine), the X-ray 318 
contrast media iopromide and iomeprol, the main metabolite of methadone (ethylidene-1,5-319 
dimethyl-3,3-diphenyl-pyrrolidine or EDDP), the sweeteners acesulfame and sucralose, the 320 
insect repellent Bayrepel and the UV filters isoamylmethoxycinnamate and ethyl hexyl 321 
dimethyl PABA. 322 
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Figure 3 illustrates the detection and tentative identification of the methadone metabolite 323 
(EDDP) in effluent wastewater by UHPLC-QTOF MS. The protonated molecule of EDDP 324 
was detected in the LE function, with a mass error of -0.6 mDa (Figure 3a, bottom). As the 325 
reference standard was not available, chemical structures for the most abundant fragment 326 
ions were suggested based on their accurate masses, using the MassFragment software 327 
(Waters). This software applies a bond-disconnecting methodology to obtain possible 328 
structures for the fragment ions from a given molecule. In order to avoid spectrum 329 
interferences that would complicate the identification process, recognizing which ions are 330 
fragments and which are not, becomes mandatory. For this purpose, UHPLC turned valuable 331 
for choosing perfectly co-eluting ions (see chromatographic peaks at 8.40 min versus the 332 
ones at 8.42, in Figure 3b). In the HE function (Figure 3a, top), up to 4 fragments (m/z 333 
249.1512, 234.1279, 186.1278 and 98.0967) were observed with chromatographic peaks at 334 
the same retention time, and mass errors lower than 1 mDa in relation to the theoretical 335 
predicted exact masses. All structures proposed for the fragments were compatible with the 336 
chemical structure of EDDP, making the identification even more reliable. Moreover, the 337 
tentative identification of EDDP was supported by the MS/MS product ions reported in the 338 
literature. Two fragments (m/z 234.1278 and 186.1277) observed in the HE spectrum had 339 
been previously reported for this compound by using an LTQ-Orbitrap with a resolving 340 
power of 30,000 [24]. After this careful evaluation process, the reference standard was finally 341 
acquired and injected, allowing the ultimate confirmation of this compound in the sample.  342 
 343 
After tentative identification, reference standards were acquired for almost all contaminants 344 
indicated above (except for isoamyl methoxycinnamate, ethyl hexyl dimethyl PABA and 345 
17 
 
Bayrepel, which are still pending), being unequivocally confirmed in all cases. After injecting 346 
the standards, the information obtained on fragmentation was subsequently included to 347 
improve the target list for future screenings.  348 
A summary of the positive findings found in the samples analyzed is shown in Figure 4. 349 
Among the detected compounds in surface water samples, around 70% corresponded to 350 
pesticides, being herbicides and fungicides the most commonly identified. The wide presence 351 
of triazine herbicides (atrazine, simazine, terbumeton, terbuthylazine and terbutryn) is 352 
noteworthy as well as their transformation products (terbumeton-desethyl, atrazine-desethyl, 353 
atrazine-desisopropyl, atrazine-2-hydroxy, terbuthylazine-desethyl and terbuthylazine-2-354 
hydroxy), which were detected in around 90% of the surface water samples (see Figure S.2). 355 
The herbicide diflufenican, the insecticide diazinon, and fungicides such as thiabendazol, 356 
fenarimol, carbendazim, propiconazole and imazalil, were also frequently found.  357 
The high number of pharmaceuticals detected in one of the surface waters is striking (Table 358 
S.3). This sample was collected in the estuary of the Mijares River, located a few kilometers 359 
downstream from the discharge point of an urban wastewater treatment plant. Valsartan and 360 
irbesartan, used for the treatment of hypertension, the antibiotics clindamicyn, lincomycin 361 
and ofloxacin, 4-aminoantipyrine-N-formyland 4-aminoantipyrine-N-acetyl (two 362 
metabolites of the analgesic metamizol, also known under the commercial trademark 363 
Nolotil®), as well as the anti-depressant venlafaxine or the anti-epileptic and mood-364 
stabilizing drug carbamazepine were found in this sample. 365 
Some personal care products (PCPs) were also found in surface water, mainly the musk 366 
tonalide and the UV filter octocrylene, which were both detected in 11 out of 12 samples 367 
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analysed. The PAHs anthracene, fluoranthene and pyrene were detected in two of the 368 
samples. 369 
Regarding ground waters, the presence of contaminants was in general much lower than in 370 
surface waters, with 76% of detections corresponding to pesticides (Figure 4). The presence 371 
of terbuthylazine and its transformation product desethyl-terbuthylazine in 11 out of 12 372 
samples analysed (Table S.3) is remarkable. Other herbicides such as atrazine, simazine, 373 
diflufenican, the transformation products atrazine-desisopropyl and terbumeton-desethyl, the 374 
insecticide chlorpyriphos-ethyl and the fungicides fenarimol and propiconazole were also 375 
detected in a large number of samples (9-10 out of 12).Concerning pharmaceuticals, it is 376 
interesting to point out the presence of several compounds in one of the samples, which 377 
contained carbamazepine, irbesartan, venlafaxine, sulfamethoxazole and phenazone. In 378 
addition, two sweeteners (acesulfame and sucralose), two X-ray agents (iomeprol and 379 
iopromide) and several preservatives were also found in this groundwater sample, which was 380 
collected near an urban wastewater treatment plant, suggesting possible influence of this 381 
plant in the groundwater of the surrounding area. Different personal care products, such as 382 
UV-filters (octocrylene, benzophenone-3 and ethylhexylmethoxycinnamate), the fragrances 383 
tonalide and galaxolide, and the insect repellent DEET were also detected in groundwater 384 
samples. 385 
 386 
In relation to effluent wastewaters, the contaminants most frequently found were pesticides 387 
(51% of total detections) followed by pharmaceuticals (30%) and drugs of abuse (3%). 388 
Similarly to the rest of water samples analysed, PCPs such as musks and UV filters, were 389 
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also detected accounting for 6-8% of the identified compounds. The insecticide chlorpyrifos-390 
ethyl and the herbicide diuron were the most detected compounds together with the 391 
fungicides thiabendazol, carbendazim and imazalil, and the triazine herbicides terbuthylazine 392 
and terbutryn. 393 
The presence of several pharmaceuticals in the same sample was rather common in effluent 394 
wastewater, with emphasis on antibiotics (ofloxacin, ciprofloxacin, azithromycin, 395 
sulfamethoxazole, sulfathiazole, trimethoprim and clarithromycin), anti-396 
inflammatory/analgesics drugs (ketoprofen, naproxen, phenazone and diclofenac) and 397 
angiotensin receptor blockers (valsartan and irbesartan). Benzodiazepines (diazepam and 398 
oxazepam), anti-depressant venlafaxine, anti-epileptic carbamazepine and veterinary 399 
pharmaceutical levamisole (also used as an adulterant in cocaine) were detected in effluent 400 
wastewater. Metabolites such as fenofibric acid (metabolite of the lipid regulator fenofibrate) 401 
and 4-aminoantipyrine, 4-aminoantipyrine-N-formyl and 4-aminoantipyrine-N-acetyl 402 
(metabolites of the analgesic metamizole/dypirone) were also found. Thus, antibiotics, 403 
NSAIDs, angiotensin II receptor antagonists and antidepressants were detected (at least one 404 
member of each family) in almost 90% of the effluent wastewater samples analysed (Figure 405 
S.2). 406 
Regarding drugs of abuse, benzoylecgonine (cocaine metabolite) was the most frequently 407 
detected. EDDP (metabolite of methadone) and cocaine were detected in two effluent 408 
wastewater samples. Other emerging contaminants, such as musks, UV-filters, 409 
antimicrobials and insect repellents were detected too.  410 
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It is worth mentioning that some of the detected compounds, such as atrazine, endosulfan, 411 
chlorpyriphos, chlorfenvinphos, diuron, simazine, trifluralin, terbutryn and the PAHs 412 
anthracene and fluoranthene, are included in the list of priority contaminants of the European 413 
Union [25]. Environmental quality standards (EQS), expressed as maximum allowable 414 
concentration, have been established for these compounds in inland surface water, mostly 415 
ranging from 0.1 to 4 µg/L (with the exception of endosulfan; EQS 0.01µg/L). All these 416 
priority compounds have been included in method validation, and SDLs have been shown to 417 
be 0.02 µg/L for all of them (0.1 µg/L for anthracene and fluoranthene). According to the 418 
data shown in this paper, the proposed screening methodology is applicable for a huge 419 
number of organic contaminants in water, including priority substances listed in the current 420 
European legislation.  421 
 422 
4. CONCLUSIONS 423 
  424 
Nowadays, thanks to recent improvements in analytical instrumentation, it is possible to 425 
advance towards the desired “universal” screening. With the complementary use of GC-426 
QTOF MS and UHPLC-QTOF MS it is possible to increase the number of investigated 427 
contaminants up to figures which were unthinkable until now. This combination allows the 428 
investigation of thousands of compounds, including pesticides, pharmaceuticals, drugs of 429 
abuse, chlorinated persistent compounds, polycyclic aromatic hydrocarbons, among others, 430 
in different types of aqueous matrices, such as ground water, surface water and effluent 431 
wastewater. The strategy applied in this work can be seen as one of the most “universal” 432 
screening approaches proposed until now, as a huge number of contaminants with very 433 
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distinct polarity and volatility, can be detected and identified at reasonably low 434 
concentrations. 435 
Another advantage of the screening method applied is that TOF MS always works under 436 
accurate-mass full-spectrum acquisition mode, which implies that MS data remain available 437 
to be reprocessed at any time. This fact allows investigating the presence of other compounds 438 
that might be of interest in the future, once data have been obtained and without the need of 439 
additional sample analysis, as well as the processing of data in a non-target way [26-27] 440 
searching for unknowns. 441 
From the point of view of the authors, the most attractive approach when investigating 442 
environmental pollution is the application of wide-scope screening methodologies, like the 443 
one proposed in this work, able to detect and identify as many organic pollutants as possible, 444 
in order to have wide and realistic information on the sample quality. In a subsequent step, 445 
those pollutants detected and considered as relevant should be included in monitoring 446 
programs that would normally apply target quantitative methods, e.g. using MS/MS with 447 
triple quadrupole analyzer. Obviously, some difficult compounds that need specific 448 
methodologies due to their high polarity, like glyphosate, glufosinate, paraquat, ethefon or 449 
fosetil-Al, should be investigated separately and, at the moment, cannot be included in any 450 
“universal” screening. Similarly, highly volatile compounds might be lost in the evaporation 451 
step included in the sample procedure, and would benefit from sample treatments directed 452 
specifically towards them. The approach proposed in this work uses an easy and rapid sample 453 
procedure as a compromise between efficiency and simplicity, trying to avoid extensive 454 
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sample handling, while the “universal” character come from the analytical measurement, able 455 
to detect the wide majority of compounds that might be present in samples.  456 
 457 
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FIGURE CAPTIONS 467 
Figure 1. Overall scheme of the screening method applied: (left) Sample treatment; (right) 468 
(Q)TOF MS data processing. 469 
Figure 2. Screening Detection Limit (SDL) for studied compounds  470 
Figure 3. Detection and identification of EDDP, main metabolite of methadone, by UHPLC-471 
QTOF MS in a wastewater sample (the reference standard was not available at our laboratory 472 
in the time of the detection): (a) LE (bottom) and HE (top) spectra of the compound eluting 473 
at 8.4 min. Proposed structures for fragment ions; (b) Extracted-ion chromatograms (0.02 Da 474 
mass width) for protonated molecule in LE function and different fragment ions in HE 475 
function. () indicates that this ion is not related with EDDP. 476 
Figure 4. Percentage of positive findings for different families of organic pollutants in 477 
ground water, surface water and effluent wastewater samples by combined screening using 478 
GC(APCI)-QTOF MS and UHPLC(ESI)-QTOF MS. 479 
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organic micropollutants in water by solid-phase microextraction combined with gas 
chromatography/high-resolution time-of-flight mass spectrometry.  Anal. Chem. 79 (2007) 9494-
9504;  
(4) F. Hernández, J.V.Sancho, M.Ibáñez, E.Abad, T.Portolés, L.Mattioli, L. Current use of 
high-resolution mass spectrometry in the environmental sciences. Anal.Bioanal.Chem.403 
(2012) 1251-1264 
(5) M. Krauss, H.Singer, J.Hollender,LC-high resolution MS in environmental analysis: from 
target screening to the identification of unknowns.Anal. Bioanal. Chem. 397 (2010) 943-951 
(6) M. Krauss,J.Hollender,Analysis of nitrosamines in wastewater: Exploring the trace level 
quantification capabilities of a hybrid linear ion trap/Orbitrap mass spectrometer. Anal. Chem. 
80 (2008)834-842 
(7) A.C. Hogenboom, J.A.van Leerdam, P.de Voogt, P.Accurate mass screening and 
identification of emerging contaminants in environmental samples by liquid chromatography-
LTQ FT Orbitrap mass spectrometry. J. Chromatogr. A 1216 (2009)510-519 
(8) J.A van Leerdam, A.C.Hogenboom,M.M.Evan der Kooi,P.deVoogt,Determination of 1H-
benzotriazoles and benzothiazoles in water sample by solid-phase extraction and liquid 
chromatography LTQ FT Orbitrap mass spectrometry. Int. J. Mass Spectrom. 282 (2009) 99-107 
(9) R. Díaz, M.Ibáñez, J.V.Sancho,F.Hernández, F.Target and non-target screening strategies 
for organic contaminants, residues and illicit substances in food, environmental and human 
biological samples by UHPLC-QTOF-MS. Anal. Methods4 (2012)4, 196-209 
(10) Y. Picó, M.Farré, C.Soler, D. Barceló, D. Identification of unknown pesticides in fruits 
using ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry: 
Imazalil as a case study of quantification, J. Chromatogr. A 1176 (2007) 123-134 
(11) M. Ibáñez, J.V. Sancho, D. McMillan, R. Ramesh, F. Hernández, Rapid non-target 
screening of organic pollutants in water by ultraperformance liquid chromatography coupled to 
time-of light mass spectrometry, TrAC-Trends Anal. Chem., 27 (2008) 481-489  
(12) M. Ibáñez, J.V. Sancho, O.Pozo, W.Niessen, W.; F. Hernández, Use of quadrupole time-
of-flight mass spectrometry in the elucidation of unknown compounds present in environmental 
water, Rapid Commun. Mass Spectrom.,19 (2005) 169-178 
(13) F. Hernández, T.Portolés, E.Pitarch, F.J.López, Gas chromatography coupled to high-
resolution time-of-flight mass spectrometry to analyze trace-level organic compounds in the 
environment, food safety and toxicology.TRAC-Trends Anal. Chem. 30 (2011)388-400   
(14) R.J.B.  Peters, A.A.M Stolker, J.G.J. Mol, A. Lommen, E.Lyris, Y. Angelis, A.Vonaparti, 
M.Stamou, C.Georgakopoulos, M.W.F.Nielen, Screening in veterinary drug analysis and sports 
doping control based on full-scan, accurate-mass spectrometry.TrAC-Trends Anal. Chem. 29 
(2010)1250-1268 
 
 25 
(15) T. Čajka, J. Hajšlova. Gas chromatography-high-resolution time-of-flight mass 
spectrometry in pesticide residue analysis: advantages and limitations. J. Chromatogr. A 1058 
(2004) 251-261. 
(16) A.H. Grange, F.A. Genicola,W.Sovocool, W.Utility of three types of mass spectrometers 
for determining elemental compositions of ions formed from chromatographically separated 
compounds. Rapid Comun. Mass Spectrom. 16 (2002) 2356-2369 
(17) D.G. Hayward,J.W. Wong,Organohalogen and organophosphorous pesticide method for 
ginseng root - A comparison of gas chromatography-single quadrupole mass spectrometry with 
high resolution time-of-flight mass spectrometry. Anal. Chem.81 (2009) 5716-5723  
(18) F. Hernández,T.Portolés,E.Pitarch,F.J.López,Searching for anthropogenic contaminants 
in human breast adipose tissues using gas chromatography-time-of-flight mass spectrometry. J. 
Mass Spectrom. 44 (2009) 1-11 
(19) M.J Gómez, M.M. Gómez-Ramos, A.Agüera, M.Mezcua, S. Herrera, A new gas 
chromatography/mass spectrometry method for the simultaneous analysis of target and non-target 
organic contaminants in waters. J. Chromatogr. A. 1216 (2009) 4071-4082.   
(20) P.M. Bastos, P. Haglund, The use of comprehensive two-dimensional gas chromatography 
and structure–activity modeling for screening and preliminary risk assessment of organic 
contaminants in soil, sediment, and surface water. J. Soils and Sed. 12 (2012) 1079-1088 
(21) T. Portolés,J.V.Sancho,F.Hernández,A.Newton,P.Hancock, Potential of atmospheric 
pressure chemical ionization source in GC-QTOF MS for pesticide residue analysis. J. Mass 
Spectrom. 45 (2010)926-936 
(22) L. Cherta, T.Portolés, J.Beltran, E.Pitarch, J.G.J.Mol,F. Hernández, Application of gas 
chromatography-(triple quadrupole) mass spectrometry with atmospheric pressure chemical 
ionization for the determination of multiclass pesticides in fruits and vegetables. J.Chromatogr. 
A 1314 (2013) 224-240. 
(23) T. Portolés, J.G.J. Mol, J. V. Sancho, F. Hernández. Use of electron ionization and 
atmospheric pressure chemical ionization in gas chromatography coupled to time-of-flight mass 
spectrometry for screening and identification of organic pollutants in waters. J. Chromatogr. A, 
1339 (2014) 145–153. 
(24) www.massbank.jp 
(25) Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013, 
amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of 
water policy. 
(26) E.L. Schymanski, H.P. Singer, P. Longrée, M. Loos, M. Ruff, M. a Stravs, et al., 
Strategies to characterize polar organic contamination in wastewater: exploring the capability of 
high resolution mass spectrometry., Environ. Sci. Technol. 48 (2014) 1811–8 
(27) C. Hug, N. Ulrich, T. Schulze, W. Brack, M. Krauss, Identification of novel 
micropollutants in wastewater by a combination of suspect and nontarget screening., Environ. 
Pollut. 184C (2014) 25–32.  
  
 26 
TABLES 
 
 
Table 1. Screening Detection Limit (SDL) for all studied compounds. The lowest SDL obtained by UHPLC-QTOF MS or GC-QTOF MS is given 
Compound  SDL (µg/L) Compound  SDL (µg/L) Compound  SDL (µg/L) Compound  SDL (µg/L) 
PESTICIDES 
Alachlor 0.1 Chlorfenvinphos 0.02 Diuron 0.02 β-HCH  0.02 
Aldrin 0.5 Chlorothalonil  - -Endosulphan 0.1 -HCH  0.02 
Atrazine 0.02 Chlorpropham 0.02 β-Endosulfan 0.02 -HCH  0.02 
Atrazine-desethyl (DEA) 0.02 Chlorpyrifos-ethyl  0.02 Endosulfan-ether 0.02 Heptachlor epoxide A 0.5 
Atrazine-desisopropyl (DIA) 0.02 Chlorpyrifos-methyl  0.1 Endosulfan-sulfate 0.1 Heptachlor epoxide B 0.5 
Atrazine-2-hydroxy 0.02 Coumaphos 0.02 Endrin 0.02 Hexachlorobutadiene 0.1 
Azinphos-methyl - Cyanazine  0.02 EPN 0.02 Hexythiazox 0.5 
Azoxystrobin 0.02 Cyanophos  0.02 Ethalfluralin 0.02 Imazalil 0.02 
Bifenthrin 0.02 Cyfluthrin  0.1 Ethion 0.02 Imidacloprid 0.02 
Boscalid 0.02 -Cyhalothrin  0.02 Ethoxyquin 0.5 Iprodione 0.5 
Bromacil 0.1 Cypermethrin 0.1 Etofenprox 0.1 Isodrin 0.5 
Bromophos 0.02 Cyprodinil  0.02 Famphur  0.02 Leptophos 0.02 
Bromophos-ethyl 0.02 p,p'-DDD 0.02 Fenamiphos  0.02 Linuron 0.02 
Buprofezin 0.02 p,p'-DDE 0.02 Fenarimol 0.02 Malathion 0.02 
Cadusafos  0.02 p,p-DDT 0.02 Fenhexamid 0.02 MCPA 0.02 
Captafol  - Deltamethrin 0.5 Fenitrothion  0.02 Metalaxyl 0.02 
Captan - Diazinon 0.02 Fenoxycarb  0.02 Methidathion 0.02 
Carbaryl  0.1 Dichlofenthion 0.02 Fenthion  0.02 Methiocarb 0.1 
Carbendazim 0.02 Dichloran  0.5 Fenvalerate  0.1 Methoxychlor  0.02 
Carbofuran 0.02 4,4'-Dichlorobenzophenone 0.02 Fipronil 0.02 Metolachlor 0.02 
Carbophenothion 0.02 Dichlorvos  0.5 Flucythrinate 0.1 Metribuzin 0.02 
Carfentrazone-ethyl 0.02 Dieldrin 0.1 Fludioxonyl  0.02 Mirex 0.1 
Chinomethionat - Diflufenican (a) Fluroxypyr - Molinate 0.02 
Trans-Chlordane 0.5 Dimethoate 0.02 -Fluvalinate 0.5 Monocrotophos 0.02 
Chlorfenapyr  0.02 Dioxathion 0.02 HCB 0.02 Omethoate 0.1 
Chlorfenson 0.02 Diphenylamine 0.02 -HCH  0.02 Oxadixyl 0.02 
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 1 
Compound  SDL (µg/L) Compound  SDL (µg/L) Compound  SDL (µg/L) Compound  SDL (µg/L) 
PESTICIDES PCBs PAHs 
Oxychlordane 0.5 Tefluthrin 0.1 PCB 28 0.1 Acenaphthene 0.1 
Oxyfluorfen 0.02 Terbacil 0.1 PCB 52 0.02 Acenaphthylene  0.1 
Parathion-ethyl 0.02 Terbufos 0.5 PCB 77 0.5 Anthracene  0.1 
Parathion-methyl 0.1 Terbumeton 0.02 PCB 81 0.5 Benzo(a)anthracene  - 
Pendimethalin 0.02 Terbumeton-desethyl 0.02 PCB 101 0.02 Benzo(b)fluoranthene  0.5 
Pentachlorobenzene 0.02 Terbuthylazine (a) PCB 105 0.02 Benzo(k)fluoranthene  0.5 
Permethrin 0.1 Terbuthylazine-desethyl (a) PCB 114 0.02 Benzo(g,h,i)perylene  - 
2-Phenylphenol 0.02 Terbuthylazine-2-hydroxy (a) PCB 118 0.02 Benzo(a)pyrene  0.5 
Phorate 0.1 Terbutryn 0.02 PCB 123 0.02 Chrysene  - 
Phosmet - Tetraconazole 0.02 PCB 126 0.5 Dibenzo(a,h)anthracene - 
Phosphamidon  - Tetradifon 0.02 PCB 138 0.02 Fluoranthene  0.1 
Pirimicarb 0.02 Thiabendazole 0.02 PCB 153 0.02 Fluorene  0.1 
Pirimiphos methyl 0.02 Thiacloprid 0.02 PCB 156 0.5 Indeno(1,2,3,cd)pyrene  - 
Procymidone  0.02 Thiobencarb 0.02 PCB 157 0.1 Naphthalene  0.1 
Promecarb - Tolclofos methyl 0.1 PCB 167 0.1 Phenanthrene 0.1 
Propachlor  0.02 Tolyfluanid 0.1 PCB 169 0.5 Pyrene  0.1 
Propanil 0.02 Triadimefon 0.02 PCB 180 0.02   
Propetamphos  0.1 Triflumizole 0.02 PCB 189 0.5   
Propham  0.1 Trifluralin 0.02     
Propiconazole 0.02 Vinclozolin 0.1     
Propoxur 0.02       
Propyzamide 0.1       
Pyridaphenthion 0.02       
Pyriproxyfen 0.02       
Quinalphos 0.02       
Resmethrin 0.1       
Simazine 0.02       
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(-) means that this compound could not be validated at any of the three levels studied 
 1 
Compound  SDL (µg/L) Compound  SDL (µg/L) Compound  SDL (µg/L) Compound  SDL (µg/L) 
PHARMACEUTICALS DRUGS OF ABUSE UV FILTERS 
4-Aminoantipyrine 0.02 Naproxen 0.1 Amphetamine - Benzophenone-2 (BP-2) 0.1 
Alprazolam 0.02 Norfloxacin - Benzoylecgonine 0.02 Benzophenone-3 (BP-3) 0.5 
Atorvastatin 0.5 Ofloxacin 0.02 Cocaethylene 0.02 Benzophenone-4 (BP-4) 0.02 
Azithromycin  0.1 Olanzapine 0.5 Cocaine 0.02   
Bezafibrate 0.02 Omeprazole 0.02 Heroin 0.02   
Carbamazepine 0.02 Oxolinic acid 0.02 Ketamine 0.02   
Chloramphenicol 0.02 Pantoprazol 0.02 MDEA  0.02   
Ciprofloxacin 0.1 Paracetamol/Acetaminophen - MDMA 0.02 PRESERVATIVES 
Clarythromycin 0.1 Paroxetine 0.5 Methamphetamine 0.02 Methylparaben 0.02 
Clindamycin 0.02 Pefloxacin 0.02 Methcathinone - Ethylparaben 0.02 
Cloxacillin 0.5 Penicillin G - Norbenzoylecgonine 0.02 Propylparaben 0.02 
Codeine 0.1 Pipedimic acid - Norcocaine 0.02 Butylparaben 0.02 
Diclofenac 0.02 Pravastatin 0.02   Triclosan/Irgasan 0.5 
Dicloxacillin 0.5 Risperidone 0.02     
Enalapril 0.5 Roxythromycin 0.5     
Enrofloxacin - Sarafloxacin 0.5     
Erythromycin A - Sulfadiazine 0.02     
Flumequine 0.02 Sulfamethazine 0.02     
Furazolidone 0.02 Sulfamethoxazole 0.02     
Furosemide  0.02 Sulfathiazole 0.02     
Gemfibrozil 0.02 Trimethoprim 0.02     
Ibuprofen 0.02 Tylosin A 0.5     
Irbesartan 0.02 Valsartan 0.02     
Ketoprofen 0.02 Venlafaxine 0.02     
Lincomycin 0.02       
Moxifloxacin 0.02       
Nalidixic acid 0.02       
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(a) the SDL could not be established as the compound was present in more than 50% of the “blank samples” used in validation. 
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-0.2 mDa
C13H12N2Cl
0.2 mDa
C7H6N
-0.1 mDa
OXAZEPAM
C15H11N2O2Cl
-0.2 mDa
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2. EXPERIMENTAL 
2.1 Reagents and chemicals 
Reference standards of organic contaminants were purchased from Dr. Ehrenstorfer (Augsburg, 
Germany), Wellington Laboratories (Guelph, Ontario, Canada), Fluka (Buchs, Switzerland), 
Riedel de Haën (Seelze, Germany), Sigma–Aldrich (St Louis, MO, USA), LGC Promochem 
(London, UK), Toronto Research Chemicals Inc. (Ontario, Canada), Across Organics (Geel, 
Belgium), Bayer Hispania (Barcelona, Spain), Fort Dodge Veterinaria (Gerona, Spain), 
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Vetoquinol Industrial (Madrid Spain) and Aventis Pharma (Madrid, Spain). All reference 
standards presented purity higher than 93%. 
HPLC-grade water was obtained by purifying demineralised water in a Milli-Q plus system from 
Millipore (Bedford, MA, USA). Acetone (residue analysis), ethyl acetate, dichloromethane, 
hexane (all ultra-trace quality), HPLC-grade acetonitrile, HPLC-grade methanol (MeOH), sodium 
hydroxide >99% (NaOH), ammonia solution (25%), and formic acid (98–100%) were acquired 
from Scharlau (Barcelona, Spain). Leucine enkephalin, used as lock mass, was purchased from 
Sigma-Aldrich. 
 
2.2 Instrumentation 
2.2.1 UHPLC-(ESI)QTOF MS 
A Waters Acquity UPLC system (Waters, Milford, MA, USA) was interfaced to a hybrid 
quadrupole-orthogonal acceleration-TOF mass spectrometer (Xevo G2 QTOF, Waters Micromass, 
Manchester, UK), using an orthogonal Z-spray-ESI interface operating in positive and negative 
ion modes. The UHPLC separation was performed using an Acquity UPLC BEH C18 1.7 µm 
particle size analytical column 100 × 2.1 mm (Waters) at a flow rate of 300 µL/min. The mobile 
phases used were A=H2O with 0.01% HCOOH and B =MeOH with 0.01% HCOOH. The 
percentage of organic modifier (B) was changed linearly as follows: 0 min, 10%; 14 min, 90%; 16 
min, 90%; 16.01 min, 10%; 18 min, 10%. Nitrogen (from a nitrogen generator) was used as the 
drying gas and nebulizing gas. The desolvation gas flow was set at 1,000 L/h and the cone gas at 
80 L/h. Capillary voltages of 0.7 and 3.0 kV were used in positive and negative ionisation modes, 
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respectively. A cone voltage of 20 V was selected for both ionisation modes. Collision gas was 
argon 99.995% (Praxair, Valencia, Spain). The interface temperature was set to 650ºC and the 
source temperature to 130ºC. The column temperature was set to 40ºC. TOF MS resolution was 
approximately 20,000 at full width half maximum (FWHM) at m/z 556. MS data were acquired 
over an m/z range of 50–1,000. A scan time of 0.4 s was selected. 
Calibration of mass axis was conducted from m/z 50 to 1,000 with a 1:1 mixture of 0.05 M 
NaOH:5% HCOOH diluted (1:25) with acetonitrile:water (80:20). For automated accurate mass 
measurement, the lock-spray probe was used, using as lockmass a solution of leucine enkephalin 
(2 µg/mL) in acetonitrile:water (50:50) at 0.1% HCOOH pumped at 20 µL/min through the lock-
spray needle. For recalibrating the mass axis and ensuring a robust accurate mass measurement 
along time, the (de)protonated molecule of leucine enkephalin was used (m/z 556.2771 in ESI+, 
m/z 554.2615 in ESI-). 
 
 
2.2.2. GC-(APCI)QTOF MS  
For the GC instrumentation, an Agilent 7890A GC system (Palo Alto, CA, USA) equipped with 
an Agilent 7683 autosampler was coupled to the Xevo G2 QTOF, operating in APCI mode. The 
GC separation was performed using a fused silica DB-5MS capillary column with a length of 30 
m x 0.25 mm i.d. and a film thickness of 0.25 µm (J&W Scientific, Folson, CA, USA). The oven 
temperature was programmed as follows: 90ºC (1 min); 5ºC/min to 300ºC (2 min). Pulsed splitless 
(50 psi) injections of 1 µL of sample extracts were carried out with an injector temperature of 280 
ºC and with a splitless time of 1 min. Helium 99.999 % (Praxair, Valencia, Spain) was used as 
carrier gas at a constant flow of 2 mL/min. The interface and source temperatures were set to 310ºC 
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and 150 ºC, respectively. The desolvation gas (N2) was set at 300 L/h flow and the cone gas at 16 
L/h. The voltage of the sampling cone was set at 20 V, the voltage of the extraction cone was 4 V, 
and the APCI corona pin was fixed at a current 1.7 µA. The ionization process occurred within an 
enclosed ion volume, which enabled control over the protonation/charge transfer processes. TOF 
MS resolution was approximately 20,000 (FWHM) at m/z 614. A scan time of 0.4 s was selected. 
MS data were acquired over an m/z range of 50-650. Heptacose was used for the daily mass 
calibration. Continuous internal calibration was performed using a background ion coming from 
the GC-column bleed as lock mass ([M-H]+ of octamethylcyclotetrasiloxane, m/z 297.0830). Two 
injections were performed for sample: the first one promoting the formation of the molecular ion, 
and the second one, promoting the formation of the protonated molecule. 
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Table S.1. Positive findings score after analysis of nine different spiked samples (3 groundwater, 3 surface and 3 effluent wastewaters) 
at different concentration levels. Screening Detection Limit (SDL) for compounds monitored by UHPLC-QTOF MS 
 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
PESTICIDES 
Alachlor 0/3 0/3 0/3  3/3 3/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Atrazine 1/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Atrazine-desethyl (DEA) 1/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Atrazine-desisopropyl (DIA) 2/3 1/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Atrazine-2-hydroxy 2/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Azoxystrobin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Boscalid 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Bromacil 0/3 0/3 1/3  3/3 1/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Bromacila 0/3 0/3 1/3  3/3 3/3 1/3 3/3 3/3 1/3 3/3 3/3 3/3 0.5 
Buprofezin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Carbaryl  0/3 0/3 0/3  2/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Carbendazim 0/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Carbofuran 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Chlorfenvinphos 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Chlorpyrifos-ethyl  0/3 0/3 1/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Chlorpyrifos-methyl 0/3 0/3 0/3  2/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Coumaphos 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Cyanazine 0/3 0/3 0/3  3/3 1/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Cyprodinil 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Dimethoate 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Diphenylamine 0/3 0/3 0/3  2/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Diuron 0/3 1/3 3/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fenarimol 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Fenhexamid 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fenitrothion  0/3 0/3 0/3  1/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Fenoxycarb 0/3 0/3 0/3  2/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Fenthion 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Fludioxonil 0/3 0/3 0/3  1/3 0/3 0/3 3/3 3/3 1/3 3/3 3/3 1/3 - 
Fludioxonila 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fluoroxypyr 0/3 0/3 0/3  1/3 0/3 0/3 3/3 3/3 1/3 3/3 3/3 1/3 - 
Fluoroxypyra 0/3 0/3 0/3  3/3 3/3 1/3 3/3 3/3 1/3 3/3 3/3 1/3 - 
Hexythiazox 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Imazalil 0/3 2/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Imidacloprid 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Linuron 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Malathion 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
MCPAa 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Metalaxyl 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Methidathion 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Methiocarb 0/3 0/3 0/3  2/3 2/3 2/3 3/3 3/3 2/3 3/3 3/3 2/3 - 
Metolachlor 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Metribuzin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Molinate  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Monocrotophos 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Omethoate 0/3 0/3 0/3  2/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Parathion-ethyl 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Parathion-methyl 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Pirimicarb 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Pirimiphos-methyl 0/3 0/3 0/3  3/3 2/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Promecarb 0/3 0/3 0/3  3/3 2/3 2/3 3/3 2/3 2/3 3/3 2/3 2/3 - 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Propachlor  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Propanil 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Propanila 1/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Propiconazole 0/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Propoxur 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Propyzamide 0/3 0/3 0/3  3/3 1/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Pyridaphenthion 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Pyriproxyfen 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Quinalphos 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Simazine 3/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Terbacila 0/3 0/3 1/3  3/3 3/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Terbumeton 2/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Terbumeton-desethyl  2/3 2/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Terbuthylazine 2/3 3/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 -b 
Terbuthylazine-desethyl 3/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 -b 
Terbuthylazine-2-hydroxy 3/3 3/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 -b 
Terbutryn 0/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Tetraconazole 0/3 2/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Thiabendazole 0/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Thiacloprid 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Thiobencarb 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Tolclofos-methyl 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Triadimefon 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PHARMACEUTICALS 
4-Aminoantipyrine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Alprazolam 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Atorvastatin 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Atorvastatina 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Azithromycin  0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Bezafibrate 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Carbamazepine 0/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Chloramphenicol 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Ciprofloxacin 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Clarythromycin 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Clindamycin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Cloxacillin 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Codeine 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Diclofenac 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Diclofenaca 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Dicloxacillin 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Enalapril 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 1/3 3/3 3/3 3/3 0.5 
Enrofloxacin 0/3 0/3 0/3  0/3 0/3 0/3 3/3 2/3 1/3 3/3 2/3 1/3 - 
Erythromycin A 0/3 0/3 0/3  0/3 0/3 0/3 1/3 3/3 1/3 1/3 3/3 1/3 - 
Flumequine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Furazolidone 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Furosemidea 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Gemfibrozil 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Gemfibrozila 0/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Ibuprofena 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Irbesartan 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Irbesartana  0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Ketoprofen 0/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Lincomycin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Moxifloxacin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Nalidixic acid 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Naproxen 0/3 0/3 1/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Norfloxacin 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 1/3 3/3 3/3 1/3 - 
Ofloxacin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Olanzapine 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Omeprazole 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Oxolinic acid 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Pantoprazol 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Paracetamol/Acetaminophen 0/3 0/3 0/3  0/3 0/3 0/3 3/3 1/3 1/3 3/3 1/3 1/3 - 
Paroxetine 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 1/3 3/3 3/3 3/3 0.5 
Pefloxacin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Penicillin G 0/3 0/3 0/3  0/3 0/3 0/3 3/3 2/3 1/3 3/3 2/3 1/3 - 
Pipedimic acid 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 1/3 3/3 3/3 1/3 - 
Pravastatin 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 1/3 3/3 3/3 3/3 0.5 
Pravastatina 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Risperidone 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Roxythromycin 0/3 0/3 0/3  3/3 3/3 1/3 3/3 3/3 1/3 3/3 3/3 3/3 0.5 
Sarafloxacin 0/3 0/3 0/3  3/3 3/3 1/3 3/3 3/3 1/3 3/3 3/3 3/3 0.5 
Sulfadiazine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Sulfamethazine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Sulfamethoxazole 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Sulfathiazole 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Trimethoprim 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Tylosin A 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Valsartan 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Valsartan 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Venlafaxine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
DRUGS OF ABUSE 
Amphetamine 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Benzoylecgonine 0/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Cocaethylene 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Cocaine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Heroin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Ketamine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
MDEA  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
MDMA 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Methamphetamine (METH) 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Methcathinone 0/3 0/3 0/3  0/3 0/3 0/3 2/3 2/3 2/3 2/3 2/3 2/3 - 
Norbenzoylecgonine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Norcocaine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
UV FILTERS 
Benzophenone-2 (BP-2) a 0/3 0/3 0/3  3/3 3/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Benzophenone-3 (BP-3) a 0/3 0/3 2/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Benzophenone-4 (BP-4) a 0/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PRESERVATIVES 
Methylparabena 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Ethylparabena 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Propylparabena 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Butylparabena 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Triclosan/Irgasana 0/3 0/3 0/3  0/3 0/3 0/3 0/3 3/3 1/3 3/3 3/3 3/3 0.5 
aInvestigated in negative ESI mode. 
bThe SDL could not be established as the compound investigated was present in more than 50% of the “blank” samples analysed.  
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Table S.2. Positive findings score after analysis of nine different spiked samples (3 groundwater, 3 surface and 3 effluent wastewaters) 
at different concentration levels. Screening Detection Limit (SDL) for compounds monitored by GC-QTOF MS 
 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
PESTICIDES 
Alachlor 0/3 0/3 0/3  2/3 3/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Aldrin 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Atrazine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Atrazine-desethyl (DEA) 0/3 1/3 0/3  1/3 1/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Atrazine-desisopropyl 
(DIA) 0/3 0/3 0/3 
 
1/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Azinphos-methyl 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Azoxystrobin 0/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Bifenthrin 1/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Bromophos 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Bromophos-ethyl 1/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Buprofezin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Cadusafos 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Captafol 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Captan 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Carbaryl 0/3 0/3 0/3  1/3 0/3 1/3 1/3 1/3 1/3 3/3 3/3 3/3 0.5 
Carbofuran 0/3 0/3 0/3  3/3 2/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Carbophenothion 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Carfentrazone-ethyl 3/3 1/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Chinomethionat 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 1/3 1/3 2/3 - 
trans-Chlordanea 0/3 0/3 0/3  0/3 0/3 0/3 1/3 2/3 2/3 3/3 3/3 3/3 0.5 
Chlorfenapyr 1/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Chlorfenson 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Chlorfenvinphos 0/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Chlorothalonil 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Chlorpropham 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Chlorpyrifos-ethyl 0/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Chlorpyrifos-methyl 0/3 0/3 0/3  2/3 3/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Coumaphos 2/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Cyanazine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Cyanophos 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Cyfluthrin 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
-Cyhalothrin 2/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Cypermethrin 0/3 0/3 0/3  0/3 1/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Cyprodinil 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
p,p'-DDDa  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
p,p'-DDEa 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
p,p-DDTa 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Deltamethrin 0/3 0/3 0/3  0/3 0/3 0/3 2/3 2/3 2/3 3/3 3/3 3/3 0.5 
Diazinon 1/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Dichlofenthion 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Dichloran 0/3 0/3 0/3  1/3 2/3 2/3 1/3 2/3 2/3 3/3 3/3 3/3 0.5 
4,4'-
Dichlorobenzophenone 0/3 0/3 0/3 
 
3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Dichlorvos 0/3 0/3 0/3  1/3 3/3 3/3 3/3 3/3 2/3 3/3 3/3 3/3 0.5 
Dieldrin 0/3 0/3 0/3  3/3 2/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Diflufenican 1/3 3/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 -b 
Dimethoate 0/3 0/3 0/3  1/3 0/3 0/3 1/3 2/3 0/3 3/3 3/3 3/3 0.5 
Dioxathion 1/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Diphenylamine 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
-Endosulphan 0/3 0/3 0/3  1/3 1/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
β-Endosulfan 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Endosulfan-ether 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Endosulfan-sulfate 0/3 0/3 0/3  0/3 1/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Endrin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
EPN 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Ethalfluralin 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Ethion 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Ethoxyquin 0/3 0/3 0/3  0/3 0/3 0/3 1/3 2/3 1/3 3/3 3/3 3/3 0.5 
Etofenprox  0/3 0/3 0/3  0/3 0/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Famphur 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fenamiphos 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fenarimol 0/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fenhexamid 0/3 0/3 0/3  0/3 0/3 1/3 1/3 0/3 1/3 3/3 3/3 3/3 0.5 
Fenitrothion  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fenoxycarb  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fenthion  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Fenvalerate  0/3 0/3 0/3  0/3 1/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Fipronil  2/3 0/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Flucythrinate  0/3 0/3 0/3  1/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
-Fluvalinate 0/3 0/3 0/3  0/3 0/3 0/3 2/3 0/3 0/3 3/3 3/3 3/3 0.5 
HCBa 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
-HCHa  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
β-HCHa  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
-HCHa  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
-HCHa  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Heptachlor epoxide A  0/3 0/3 0/3  0/3 0/3 0/3 1/3 1/3 2/3 3/3 3/3 3/3 0.5 
Heptachlor epoxide B  0/3 0/3 0/3  1/3 2/3 1/3 3/3 3/3 2/3 3/3 3/3 3/3 0.5 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Hexachlorobutadienea 0/3 0/3 0/3  0/3 1/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Imazalil  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Iprodione  0/3 0/3 1/3  0/3 0/3 2/3 0/3 1/3 2/3 3/3 3/3 3/3 0.5 
Isodrin  0/3 0/3 0/3  0/3 0/3 0/3 0/3 2/3 2/3 3/3 3/3 3/3 0.5 
Leptophos  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Malathion  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Metalaxyl  0/3 0/3 0/3  2/3 3/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Methidathion  0/3 0/3 0/3  1/3 1/3 0/3 1/3 2/3 2/3 3/3 3/3 3/3 0.5 
Methiocarb  0/3 0/3 0/3  0/3 1/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Methoxychlor  1/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Metolachlor  0/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Metribuzin  0/3 0/3 0/3  1/3 1/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Mirexa  0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Molinate  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Omethoate 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Oxadixyl  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Oxychlordane  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Oxyfluorfen  0/3 1/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Parathion ethyl  0/3 0/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Parathion methyl  0/3 0/3 0/3  2/3 3/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Pendimethalin  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Pentachlorobenzenea 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Permethrin  0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
2-Phenylphenol  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Phorate 0/3 0/3 0/3  1/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Phosmet  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Phosphamidon  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Pirimicarb  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Pirimiphos-methyl 1/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Procymidone  1/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Propetamphos  0/3 0/3 0/3  1/3 2/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Propham  0/3 0/3 0/3  2/3 2/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Propiconazole  1/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Propoxur  0/3 0/3 0/3  1/3 1/3 1/3 2/3 3/3 2/3 3/3 3/3 3/3 0.5 
Propyzamide  0/3 0/3 0/3  2/3 1/3 1/3 1/3 3/3 1/3 3/3 3/3 3/3 0.5 
Pyriproxyfen  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Quinalphos  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Resmethrin  0/3 0/3 0/3  2/3 0/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Simazine  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Tefluthrin  0/3 0/3 0/3  2/3 2/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Terbacil  0/3 0/3 0/3  1/3 2/3 0/3 1/3 2/3 2/3 3/3 3/3 3/3 0.5 
Terbufos 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Terbumeton  2/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Terbumeton-desethyl  2/3 1/3 0/3  2/3 3/3 1/3 2/3 2/3 2/3 3/3 3/3 3/3 0.5 
Terbuthylazine  3/3 3/3 2/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 -b 
Terbuthylazine-desethyl 3/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 -b 
Terbutryn  0/3 2/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Tetradifon  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Thiabendazole  0/3 0/3 1/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Tolclofos-methyl  0/3 0/3 0/3  2/3 3/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Tolyfluanid  0/3 0/3 0/3  0/3 1/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Triadimefon  0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Triflumizole 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
Trifluralin  0/3 1/3 1/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Vinclozolin  0/3 0/3 0/3  2/3 3/3 2/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
PCBs 
PCB 28a 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
PCB 52 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 77 a 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
PCB 81 a 0/3 0/3 0/3  0/3 0/3 0/3 0/3 1/3 1/3 3/3 3/3 3/3 0.5 
PCB 101 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 105 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 114 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 118 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 123 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 126 a 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
PCB 138 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 153 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 156 a 0/3 0/3 0/3  0/3 0/3 0/3 0/3 1/3 1/3 3/3 3/3 3/3 0.5 
PCB 157 a 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
PCB 167 a 0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
PCB 169 a 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
PCB 180 a 0/3 0/3 0/3  3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.02 
PCB 189 a 0/3 0/3 0/3  0/3 0/3 0/3 0/3 1/3 1/3 3/3 3/3 3/3 0.5 
PAHs 
Acenaphthene  0/3 0/3 0/3  1/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Acenaphthylene  0/3 0/3 0/3  0/3 1/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Anthracene  0/3 0/3 0/3  0/3 1/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Benzo(a)anthracene  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Benzo(b)fluoranthene  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Benzo(k)fluoranthene 0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
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 Blank samples  0.02 µg/L 0.1 µg/L 0.5 µg/L SDL 
(µg/L) Compounds GW SW EWW  GW SW EWW GW SW EWW GW SW EWW 
Benzo(g,h,i)perylene  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Benzo(a)pyrene  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 3/3 3/3 3/3 0.5 
Chrysene  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Dibenzo(a,h)anthracene  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Fluoranthene  0/3 0/3 0/3  1/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Fluorene  0/3 0/3 0/3  0/3 0/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Indeno(1,2,3,cd)pyrene  0/3 0/3 0/3  0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 - 
Naphthalene  0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Phenanthrene  0/3 0/3 0/3  0/3 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
Pyrene  0/3 0/3 0/3  0/3 0/3 1/3 3/3 3/3 3/3 3/3 3/3 3/3 0.1 
aInvestigated under charge transfer conditions, this is, without adding water as modifier in the source and therefore favouring the 
formation of M+· . 
bThe SDL could not be established as the compound investigated was present in more than 50% of the “blank” samples analysed. 
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Table S.3. Positive findings (detected and confirmed) in water samples 
COMPOUND/TYPE OF WATER GW (n=12) SW (n=12) EWW (n=9) 
PESTICIDES 
Atrazine 10/12 7/12 3/9 
Atrazine-desethyl (DEA) 8/12 6/12 1/9 
Atrazine-desisopropyl (DIA) 10/12 6/12 1/9 
Atrazine-2-hydroxy 3/12 3/12 0/9 
2-phenylphenol 3/12 6/12 3/9 
4,4’-dichlorobenzophenone 1/12 2/12 0/9 
Aldicarb-sulfoxide 1/12 0/12 1/9 
Azoxystrobin 3/12 5/12 1/9 
Bifenthrin 1/12 0/12 0/9 
Bromacil 4/12 0/12 1/9 
Bromophos-ethyl 2/12 0/12 1/9 
Buprofezin 0/12 0/12 1/9 
Carbendazim 6/12 9/12 7/9 
Carfentrazone-ethyl 3/12 1/12 0/9 
Chlorfenapyr  3/12 2/12 0/9 
Chlorfenson 1/12 4/12 0/9 
Chlorfenvinphos 2/12 3/12 6/9 
Chlorpropham 5/12 4/12 3/9 
Chlorpyriphos-ethyl 9/12 11/12 9/9 
Chlorpyriphos-methyl 0/12 0/12 1/9 
Cianazine 1/12 0/12 0/9 
Coumaphos 4/12 4/12 2/9 
Cyprodinil 0/12 0/12 1/9 
Diazinon 8/12 9/12 6/9 
Dichlofenthion 0/12 2/12 1/9 
Dieldrin 1/12 0/12 1/9 
Diflufenican 9/12 10/12 4/9 
Dimethoathe 4/12 3/12 2/9 
Dioxathion 1/12 0/12 1/9 
Diuron 2/12 0/12 8/9 
-Endosulfan 0/12 0/12 1/9 
β-Endosulfan 0/12 0/12 1/9 
Endosulfan-ether 0/12 1/12 0/9 
Endrin 0/12 0/12 1/9 
Etofenprox 0/12 1/12 0/9 
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COMPOUND/TYPE OF WATER GW (n=12) SW (n=12) EWW (n=9) 
Famphur 1/12 1/12 0/9 
Fenamiphos 4/12 4/12 0/9 
Fenarimol 9/12 9/12 1/9 
Fenexhamid 2/12 1/12 0/9 
Fenithrotion 0/12 2/12 2/9 
Fenthion 0/12 0/12 1/9 
Fipronil 4/12 5/12 6/9 
Imazalil 6/12 7/12 7/9 
Imidacloprid 1/12 0/12 0/9 
Iprodione 1/12 1/12 1/9 
-Cyhalothrin 4/12 0/12 0/9 
Leptophos 1/12 0/12 1/9 
Metalaxyl 3/12 4/12 3/9 
Metolachlor 2/12 2/12 1/9 
Metoxychlor 3/12 1/12 2/9 
Mycoblutanil 0/12 0/12 2/9 
Oxadixyl 0/12 1/12 0/9 
Oxyfluorfen 5/12 5/12 2/9 
Parathion-ethyl 1/12 0/12 1/9 
Penconazole 0/12 0/12 1/9 
Pendimethanlin 0/12 0/12 1/9 
Permethrin 0/12 0/12 1/9 
Pirimiphos-methyl 5/12 4/12 2/9 
Procymidone 1/12 0/12 0/9 
Propanil 0/12 0/12 1/9 
Propiconazole 9/12 8/12 6/9 
Propoxur 0/12 0/12 2/9 
Pyriproxyfen 3/12 1/12 1/9 
Simazine 10/12 8/12 3/9 
Tebuconazole 0/12 0/12 4/9 
Terbacilo 4/12 3/12 0/9 
Terbumeton 5/12 4/12 2/9 
Terbumeton-desethyl 10/12 4/12 2/9 
Terbuthylazine 11/12 10/12 9/9 
Terbuthylazine-desethyl 11/12 10/12 6/9 
Terbuthylazine-2-hydroxy 7/12 10/12 1/9 
Terbutryn 7/12 10/12 9/9 
Tetradifon 1/12 0/12 1/9 
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COMPOUND/TYPE OF WATER GW (n=12) SW (n=12) EWW (n=9) 
Thiabendazol 4/12 8/12 9/9 
Triadimefon 4/12 6/12 0/9 
Triadimenol 0/12 0/12 1/9 
Triflumizole 6/12 7/12 1/9 
Trifluralin 0/12 0/12 1/9 
DRUGS OF ABUSE 
Caffeine 0/12 2/12 0/9 
Cocaine 0/12 0/12 2/9 
Benzoylecgonine 0/12 2/12 7/9 
EDDP 0/12 0/12 2/9 
PHARMACEUTICALS 
4-Aminoantipyrine 0/12 0/12 1/9 
4-Aminoantipyrine-N-acetyl 0/12 1/12 5/9 
4-Aminoantipyrine-N-formyl 0/12 1/12 5/9 
Azithromycin 0/12 0/12 1/9 
Carbamazepine 1/12 1/12 8/9 
Ciprofloxacin 0/12 0/12 2/9 
Clarithromycin 0/12 0/12 1/9 
Clindamycin 0/12 1/12 0/9 
Diazepam 0/12 0/12 2/9 
Diclofenac 0/12 0/12 8/9 
Fenofibric acid 0/12 0/12 3/9 
Irbesartan 1/12 1/12 8/9 
Ketoprofen 0/12 0/12 3/9 
Levamisole 0/12 0/12 1/9 
Lincomycin 0/12 1/12 0/9 
Naproxen 0/12 0/12 4/9 
Ofloxacin 0/12 1/12 7/9 
Oxazepam 0/12 0/12 3/9 
Phenazone 1/12 0/12 1/9 
Sulfamethoxazole 1/12 0/12 1/9 
Sulfathiazole 0/12 0/12 1/9 
Trimethoprim 0/12 0/12 2/9 
Valsartan 0/12 1/12 7/9 
Venlafaxine 1/12 1/12 7/9 
Preservatives 
Butylparaben 2/12 0/12 0/9 
Gabapentin 1/12 0/12 0/9 
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COMPOUND/TYPE OF WATER GW (n=12) SW (n=12) EWW (n=9) 
Methylparaben 2/12 0/12 0/9 
Propylparaben 2/12 0/12 0/9 
Sweeteners 
Acesulfame 1/12 0/12 0/9 
Sucralose 1/12 0/12 0/9 
X-RAY AGENTS 
Iomeprol 1/12 0/12 0/9 
Iopromide 1/12 0/12 0/9 
PAHs 
Anthracene 1/12 0/12 0/9 
Fluoranthene 1/12 2/12 1/9 
Pyrene 1/12 2/12 1/9 
MUSKS  
Galaxolide 7/12 6/12 7/9 
Tonalide 10/12 11/12 8/9 
UV FILTERS 
Benzophenone-3 5/12 2/12 3/9 
Ethylhexyl methoxycinnamate  (EHMC) 7/12 5/12 3/9 
Ethylhexyl dimethyl PABA* 0/12 0/12 7/9 
Isoamyl methoxcynnamate* 0/12 2/12 1/9 
Octocrylene 10/12 11/12 6/9 
ANTIMICROBIALS 
Triclosan 0/12 1/12 2/9 
INSECT REPELLENTS 
Bayrepel* 0/12 0/12 1/9 
N,N-Diethyl-meta-toluamide (DEET) 6/12 5/12 6/9 
*Pending of confirmation as reference standard is not available at our laboratory at this moment. 
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Figure S.1. Detection and identification of the insecticide chlorpyrifos by GC-QTOF MS in a 
wastewater sample. LE (bottom) and HE (top) spectra, and proposed fragment ions structures. 
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Figure S.2. Compounds most frequently detected (pesticides and pharmaceuticals) in ground water, surface water and effluent 
wastewater samples analysed 
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